Advances in 3D spatial multiomics are changing how researchers study tissue architecture. We spoke with Stellaromics' CEO, Dr. Todd Dickinson, to learn how this approach preserves structure and ...

The global spatial biology market is projected to grow at a compound annual growth rate (CAGR) of approximately 15% over the next five years. Key factors fueling this growth include the rising ...

On this episode of GEN Live, we deliver a full debrief on the news from AGBT—critical to understanding where NGS, spatial, single-cell, and multiomics are headed.

Rare tumors, although individually uncommon, collectively account for a considerable proportion of cancer diagnoses and pose unique clinical and biological ...

The field of liver research has benefited enormously from technological breakthroughs. We now have access to single-cell ...

Illumina, Inc. (NASDAQ:ILMN) Q4 2025 Earnings Call Transcript February 5, 2026 Illumina, Inc. beats earnings expectations. Reported EPS is $1.35, expectations were $1.26. Operator: Good day, ladies ...

Aquaculture is critical for global food security, yet bacterial diseases remain a persistent challenge that threatens animal welfare and farm profitability.

A new software tool, ovrlpy, improves quality control in spatial transcriptomics, a key technology in biomedical research. Developed by the Berlin Institute of Health at Charité (BIH) in international ...

Spatial omics is a new generation of technologies that allow scientists to study cells in their original location within ...

Stellaromics, announced the installation of its first U.S.-based Pyxa™ system at the University of California, Irvine (UCI). This milestone marks a significant expansion of Stellaromics' global beta ...